xcellbio

Xcell Biosciences, based in San Francisco, CA, is a cutting-edge technology company focused on advancing cell and gene therapy manufacturing. Their mission is to enhance the performance and safety of these therapies through the design and development of revolutionary technology platforms. Xcellbio has developed a suite of products and services including the AVATAR system, a cell culturing platform designed specifically for primary human cells, and the AVATAR Foundry, a cGMP cell therapy manufacturing platform that delivers novel capabilities for improving the potency of cell and gene therapies. The company has also developed the AVATAR AI, a tumor microenvironment focused cell and drug screening platform that predicts drug behavior and allows users to develop rapid and accurate potency assays for cell therapy products.

Xcellbio's focus on improving the efficacy and safety of cell and gene therapies is driven by the company's understanding of the limitations of current technologies and the need to overcome the challenges of the tumor microenvironment. Through their unique approach to metabolic conditioning, Xcellbio is working to develop cell therapies that are more potent, persistent, and effective in treating a broader range of cancers, including solid tumors. They are actively partnering with industry leaders like AmplifyBio and Labcorp to advance the development and commercialization of next-generation cell and gene therapies, making a significant impact on the future of healthcare.

Xcell Biosciences is driven by the mission to enhance the performance and safety of cell and gene-based therapies through the design and development of revolutionary technology platforms. They develop commercial instruments and software that allow researchers to gain novel insights into immune and tumor biology, and translate these insights into patient-scale treatment through the development of a pioneering cGMP cell therapy manufacturing platform.

Xcellbio promotes a culture of innovation and collaboration, focused on developing cutting-edge cell and gene therapy technologies to combat cancer. They emphasize a team-oriented approach with experts in cell therapy and platform technology development, driven by a shared mission to enhance the performance and safety of these therapies. The company values scientific rigor and a commitment to translating research into impactful solutions, creating a dynamic and exciting environment for employees.